Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Listen to Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of molecular testing and classification to guide the treatment of patients with endometrial cancer.
This podcast is intended for clinicians practicing medicine outside of the United States.
In this episode, Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of molecular testing and classification to guide the use of immunotherapy for the treatment of patients with endometrial cancer.
Ana Oaknin, MD, PhD
Head of Gynecologic Tumors Unit
Medical Oncology Department
Vall d´Hebron University Hospital
Mansoor Raza Mirza, MD
Department of Oncology,
Rigshopitalet – Copenhagen University Hospital
Comentario clínico en español sobre la reclasificación molecular de los cánceres de endometrio y ensayos clave de inmunoterapia en curso, de Clinical Care Options (CCO)
Jubilee Brown, MD, and Ursula Matulonis, MD, discuss current challenges in the management of endometrial and ovarian cancer, from Clinical Care Options (CCO)
Download slides from Clinical Care Options (CCO) in which experts provide multidisciplinary insights on the use of checkpoint inhibitors for HCC
From Clinical Care Options (CCO), webcast and downloadable slides on the use of PARP inhibitors to treat ovarian cancer, with Italian subtitles